198 related articles for article (PubMed ID: 32321685)
1. Seroprevalences of antibodies against pertussis, diphtheria, tetanus, measles, mumps and rubella: A cross-sectional study in children following vaccination procedure in Guangzhou, China.
Li YT; Luo XQ; Zhong XB; Cai LM; Zhu LP; Chen XQ; Wang KC; Chen ZG
Vaccine; 2020 May; 38(23):3960-3967. PubMed ID: 32321685
[TBL] [Abstract][Full Text] [Related]
2. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.
Theeten H; Hutse V; Hens N; Yavuz Y; Hoppenbrouwers K; Beutels P; Vranckx R; Van Damme P
Epidemiol Infect; 2011 Apr; 139(4):494-504. PubMed ID: 20587123
[TBL] [Abstract][Full Text] [Related]
3. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.
Heijstek MW; van Gageldonk PG; Berbers GA; Wulffraat NM
Ann Rheum Dis; 2012 Jun; 71(6):948-54. PubMed ID: 22172491
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of Maternal and Cord Antibodies Specific for Diphtheria, Tetanus, Pertussis, Measles, Mumps and Rubella in Shunyi, Beijing.
Meng QH; Liu Y; Yu JQ; Li LJ; Shi W; Shen YJ; Li L; Zhan SN; Yang F; Wang YJ; Yao KH
Sci Rep; 2018 Aug; 8(1):13021. PubMed ID: 30158679
[TBL] [Abstract][Full Text] [Related]
5. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of antibodies against diphtheria, tetanus, and pertussis among healthy Thai adolescents.
Hanvatananukul P; Prasarakee C; Sarachai S; Aurpibul L; Sintupat K; Khampan R; Saheng J; Sudjaritruk T
Int J Infect Dis; 2020 Jul; 96():422-430. PubMed ID: 32387447
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of diphtheria and pertussis immunoglobulin G among children with pneumonia in Ji'nan, China.
Meng Q; Li L; Shi W; Wang Q; Ding M; Liu Y; Ma X; Yao K
BMC Pediatr; 2018 Dec; 18(1):383. PubMed ID: 30518371
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China.
Zhang Q; Han F; Nie Q; Ren H; Zhang B; Liu Q; He Q; Shao Z
J Infect; 2011 Dec; 63(6):441-6. PubMed ID: 21864569
[TBL] [Abstract][Full Text] [Related]
9. High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students.
Socan M; Berginc N
Wien Klin Wochenschr; 2008; 120(13-14):422-6. PubMed ID: 18726668
[TBL] [Abstract][Full Text] [Related]
10. Vaccination update. Diphtheria, tetanus, pertussis, mumps, rubella, measles.
Vetter RT; Johnson GM
Postgrad Med; 1995 Oct; 98(4):133-7, 141-2, 144-5 passim. PubMed ID: 7567714
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of measles, mumps & rubella antibodies among 5-10 years old children in north India.
Gupta M; Tripathy JP; Verma M; Singh MP; Kaur R; Ratho RK; Kumar R
Indian J Med Res; 2019 Mar; 149(3):396-403. PubMed ID: 31249206
[TBL] [Abstract][Full Text] [Related]
12. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
[TBL] [Abstract][Full Text] [Related]
13. Low seroprevalence of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination.
Tanriover MD; Soyler C; Ascioglu S; Cankurtaran M; Unal S
Eur J Intern Med; 2014 Jul; 25(6):528-32. PubMed ID: 24814432
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel.
Levine H; Zarka S; Ankol OE; Rozhavski V; Davidovitch N; Aboudy Y; Balicer RD
Hum Vaccin Immunother; 2015; 11(6):1400-5. PubMed ID: 25891446
[TBL] [Abstract][Full Text] [Related]
15. Pertussis, diphtheria, and tetanus antibodies seroprevalence in pregnant women and neonates, as a preliminary data for introduction of preconception or prenatal DTaP vaccination among Japanese society.
Tsurane K; Umehara N; Nakayama T; Okada K; Inoue M; Ogawa K; Sago H; Miyasaka N; Yamaguchi K
Vaccine; 2022 Nov; 40(49):7122-7129. PubMed ID: 36404430
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of Measles, Rubella, Tetanus, and Diphtheria Antibodies among Children in Haiti, 2017.
Minta AA; Andre-Alboth J; Childs L; Nace D; Rey-Benito G; Boncy J; Adrien P; Francois J; Phaïmyr Jn Charles N; Blot V; Vanden Eng J; Priest JW; Rogier E; Tohme RA
Am J Trop Med Hyg; 2020 Oct; 103(4):1717-1725. PubMed ID: 32618256
[TBL] [Abstract][Full Text] [Related]
17. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
Matter L; Germann D; Bally F; Schopfer K
Eur J Epidemiol; 1997 Jan; 13(1):61-6. PubMed ID: 9062781
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to measles, mumps, and rubella virus in Thai children after two-dose vaccination at 9 months and 2.5 years: A longitudinal study.
Wanlapakorn N; Puenpa J; Thongmee T; Srimuan D; Thatsanathorn T; Vongpunsawad S; Poovorawan Y
Vaccine; 2020 May; 38(24):4016-4023. PubMed ID: 32331806
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
Sultana R; Rahman MM; Hassan Z; Hassan MS
Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
[TBL] [Abstract][Full Text] [Related]
20. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination.
Wang Z; Yan R; He H; Li Q; Chen G; Yang S; Chen E
PLoS One; 2014; 9(2):e89361. PubMed ID: 24586717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
